Výsledky vyhledávání - "Arwin Ridder"

Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)

Autor: Sang Jin Yoon, Asha Paireddy, Tomasz Rechberger, Salman Al-Shukri, Dudley Robinson, Arwin Ridder, Sender Herschorn, Christopher R. Chapple, Matthias Stoelzel, Rob van Maanen, Paul Abrams, Christian Gratzke, Elizabeth R. Mueller

Publikováno v: European Urology. 74:501-509

Background The long-term potential of solifenacin and mirabegron combination treatment for patients with overactive bladder (OAB) has not been previously assessed. Objectives To evaluate the safety and efficacy of solifenacin succinate 5mg plus mirab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c85f7a85780ece96b72ab909dd4f6043
https://doi.org/10.1016/j.eururo.2018.05.005

Zobrazit plný text záznamu

Cardiovascular Safety of the β3-Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial

Autor: Asha Paireddy, Christian Gratzke, Michael A. Weber, Jeffrey Frankel, Matthias Stoelzel, Arwin Ridder, Dudley Robinson, Christopher R. Chapple, Robert van Maanen, Sender Herschorn, William B. White

Publikováno v: The Journal of Clinical Pharmacology. 58:1084-1091

There have been concerns that treatment of overactive bladder with β3 -adrenoceptor agonists may potentially have detrimental cardiovascular (CV) side effects. We evaluated the CV safety of mirabegron, a β3 -adrenoceptor agonist, alone and in combi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f1ea6d90c44e662fee6815cb7e774854
https://doi.org/10.1002/jcph.1107

Zobrazit plný text záznamu

Patient and physician preferences for oral pharmacotherapy for overactive bladder: two discrete choice experiments

Autor: Matthias Stoelzel, R. van Maanen, Arwin Ridder, Stefan A. Baeten, M Marieke Heisen, Elly A. Stolk, Zalmai Hakimi, B.G. Verheggen

Publikováno v: Current Medical Research and Opinion. 32:787-796

We examined patient and treating physician (general practitioners, urologists, and [uro]gynecologists) preferences for oral pharmacotherapy (antimuscarinics and beta-3 adrenoceptor agonists) for overactive bladder to gain a deeper understanding of wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae9c22861834b04486b9f6cdcce2411f
https://doi.org/10.1185/03007995.2016.1142959

Zobrazit plný text záznamu

A quantitative benefit-risk assessment approach to improve decision making in drug development: Application of a multicriteria decision analysis model in the development of combination therapy for overactive bladder

Autor: I de Greef-van der Sandt, R. van Maanen, Reynaldo Martina, Arwin Ridder, Donald Newgreen, C Dorrepaal, M Schaddelee

Publikováno v: Clinical Pharmacology & Therapeutics. 99:442-451

A multicriteria decision analysis (MCDA) approach was developed and used to estimate the benefit-risk of solifenacin and mirabegron and their combination in the treatment of overactive bladder (OAB). The objectives were 1) to develop an MCDA tool to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::131ef67ff7fe21375dc059cf48d7266e
https://doi.org/10.1002/cpt.271

Zobrazit plný text záznamu

Electronic bladder diaries of differing duration versus a paper diary for data collection in overactive bladder

Autor: Trudy Kuipers-deGroot, Asha Paireddy, Rob van Maanen, Reynaldo Martina, Arwin Ridder, Donald Newgreen, Jean Paty, Paul Abrams

Publikováno v: Neurourology and Urodynamics. 35:743-749

Aims This observational study compared data values, reliability, consistency and compliance collected by electronic and paper diaries of differing durations. Methods Subjects ≥18 years with overactive bladder (OAB) on stable antimuscarinic treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2627d9e20a842d3ef465bfcd3ecf87be
https://doi.org/10.1002/nau.22800

Zobrazit plný text záznamu

A clinical perspective on the analysis and presentation of the number of incontinence episodes following treatment for OAB

Autor: Robert van Maanen, Paul Abrams, Richard Kay, Reynaldo Martina, Arwin Ridder

Publikováno v: Neurourology and Urodynamics. 35:728-732

Aims To provide a clinical view and interpretation on the methods for analysis of incontinence in patients with overactive bladder. Methods Results are analyzed using the total number of incontinence episodes in a 3-day diary period, using fixed and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e3019a2b7511a78ceca1e868f22bb56d
https://doi.org/10.1002/nau.22787

Zobrazit plný text záznamu

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)

Autor: Matthias Stoelzel, Arwin Ridder, Kyu-Sung Lee, Salvador Arlandis, Dudley Robinson, Sender Herschorn, Rob van Maanen, David Mitcheson, Asha Paireddy, Christopher R. Chapple, Paul Abrams

Publikováno v: BJU INTERNATIONAL
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Objective To evaluate the potential of solifenacin 5 mg combined with mirabegron 25 or 50 mg to deliver superior efficacy compared with monotherapy, with acceptable tolerability, in the general overactive bladder (OAB) population with urinary inconti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62156a3e09ef9703a15e820dd0eb4426
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=6867

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání